diltiazem has been researched along with Uveitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shalaby, U | 1 |
| Ishida, S; Koto, T; Nagai, N; Oike, Y | 1 |
1 trial(s) available for diltiazem and Uveitis
| Article | Year |
|---|---|
Diltiazem co treatment with cyclosporine for induction of disease remission in sight-threatening non-infectious intraocular inflammation.
Topics: Adult; Cyclosporine; Diltiazem; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Remission Induction; Uveitis; Vasodilator Agents | 2017 |
1 other study(ies) available for diltiazem and Uveitis
| Article | Year |
|---|---|
Calcium channel blocker nilvadipine, but not diltiazem, inhibits ocular inflammation in endotoxin-induced uveitis.
Topics: Animals; Blood-Aqueous Barrier; Calcium Channel Blockers; Cell Adhesion; Chemokine CCL2; Diltiazem; Disease Models, Animal; Endotoxins; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Inflammation; Intercellular Adhesion Molecule-1; Leukocyte Count; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Nifedipine; Retina; Retinal Vessels; Uveitis | 2010 |